CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients

ABSTRACT:

SUBMITTER: Ghandili S 

PROVIDER: S-EPMC8701540 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature